SunTrust Robinson Humphrey
https://www.suntrustrh.com/r.ashx?pid=3SunTrust Robinson Humphrey is the investment banking division of SunTrust Banks (NYSE: STI). To serve the needs of corporate clients across the nation, the firm’s services include capital raising, strategic advisory, risk management, and investment solutions. It also offers fixed income, equity research, and sales and trading to institutional investors.
View Older Stories View More Recent Stories
-
PennantPark Floating Rate Capital (PFLT) to Sell 5M Shares at $14.08
-
PennantPark Floating Rate Capital Ltd. Prices Public Offering
-
SunTrust Robinson Humphrey Downgrades Hibbett Sports (HIBB) to Hold
-
PennantPark Floating Rate Capital (PFLT) Announces Public Offering of Common Stock
-
PennantPark Floating Rate Capital Ltd. Announces Public Offering
-
NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th
-
SunTrust Robinson Humphrey Upgrades Seacoast Banking (SBCF) to Buy
-
Foundation Building Materials (FBM) IPO Opens Up 13%
-
Twitter (TWTR) PT Lowered to $16 at SunTrust Robinson Humphrey on 4Q Miss, Lower Outlook
-
SunTrust Starts Penn National Gaming (PENN) at Hold
-
SunTrust Starts Boyd Gaming (BYD) at Buy
-
SunTrust Upgrades Golden Entertainment (GDEN) to Buy
-
SunTrust Robinson Humphrey Starts Pinnacle Entertainment (PNK) at Hold
-
SunTrust Upgrades Medidata Solutions (MDSO) to Buy
-
SunTrust Upgrades Jack In The Box (JACK) to Buy
-
LPL Investment (LPLA) PT Raised to $42 at SunTrust Robinson Humphrey on 4Q16 EPS Beat
-
Foundation Building Materials (FBM) IPO Prices at $14, Below Expected Range
-
Foundation Building Materials Announces Pricing Of Initial Public Offering At $14.00 Per Share
-
Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphrey’s 2017 Orphan Drug Day
-
Sierra Oncology (SRRA) Prices 19.5M Shares at $1.35
-
Sierra Oncology Announces Pricing of Public Offering of Common Stock
-
SunTrust Says Tesaro (TSRO) M&A Valuation Is ~$250/Share
-
Compass Diversified (CODI): Strong Checks Offset Equity Dilution - Suntrust
-
Sage Therapeutics to Participate in Upcoming February Investor Conferences
-
MPLX LP prices $2.25 billion senior notes offering
-
Cerecor (CERC) Engaged SunTrust Robinson Humphrey to Explore Strategic Alternatives
-
Cerecor Engages SunTrust Robinson Humphrey to Assist with Review of Strategic Alternatives
-
MPLX LP announces senior notes offering
-
IAC/InterActiveCorp (IAC) PT Raised to $82 at SunTrust Robinson Humphrey
-
SunTrust Downgrades Natural Grocers (NGVC) to Hold
-
SunTrust Downgrades Tractor Supply Company (TSCO) to Hold
-
Voyager Therapeutics to Attend Upcoming Investor Conferences
-
Madison Dearborn Partners Completes Acquisition of Intermedia
-
Summit Therapeutics to Participate in February Investor Conferences
-
REGENXBIO to Participate in the SunTrust Robinson Humphrey 2017 Orphan Drug Day
-
Foundation Building Materials Announces Proposed Initial Public Offering
-
SunTrust Downgrades Tempur Sealy (TPX) to Sell
-
Fitbit estimates lower fourth-quarter revenue, to cut jobs
-
Eiger BioPharmaceuticals to Present at BIO CEO & Investor Conference February 13th and Participate in SunTrust Robinson Humphrey Orphan Drug Day Conference February 14th
-
SunTrust Robinson Humphrey Downgrades CONSOL Energy (CNX) to Hold
-
SunTrust Robinson Humphrey Downgrades Rice Energy (RICE) to Hold
-
JELD-WEN (JELD) IPO Opens Up 10%
-
KeyW Holding (KEYW) 8.5M Share Offering Prices at $10.50
-
KeyW Announces Pricing of Public Offering of Common Stock
-
E*TRADE (ETFC) PT Raised to $42 at SunTrust Robinson Humphrey Amid Solid Q4 Results
-
JELD-WEN (JELD) Prices IPO at $23, Top End of Range
-
JELD-WEN Announces Pricing of Initial Public Offering
-
KeyW (KEYW) Announces 8.5M Public Offering of Common Stock
-
KeyW Announces Public Offering of Common Stock
-
Spark Therapeutics to Participate in Multiple February Conferences

